We are live on ! Find out more
OMIC

Singular Genomics Systems, Inc. Common Stock
OMIC

Delisted

OMIC was delisted on the 20th of February, 2025.

Back to rankings

42 hedge funds and large institutions have $13.1M invested in Singular Genomics Systems, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $12.1M → $13.1M (+$964K)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

11% less funds holding

Funds holding: 47 → 42 (-5)

30% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 10

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

Holders
42
Holders Change
-5
Holders Change %
-10.64%
% of All Funds
0.6%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
7
Reduced
10
Closed
7
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
+$6K

Top Buyers

Rank Fund Capital Flow
1
QM
QVIDTVM Management
Texas
+$95.1K
2
HighTower Advisors
HighTower Advisors
Illinois
+$55.9K
3
Citadel Advisors
Citadel Advisors
Florida
+$36K
4
Millennium Management
Millennium Management
New York
+$29.6K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$26K

Top Sellers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$481K
2
BlackRock
BlackRock
New York
-$48.3K
3
WC
Weil Company
California
-$35.6K
4
Renaissance Technologies
Renaissance Technologies
New York
-$20.5K
5
XT
XTX Topco
Cayman Islands
-$16.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$20K -$6.59K -432 -25%
DIM
27
DLK Investment Management
California
$12.9K – – –
XT
28
XTX Topco
Cayman Islands
$12.6K -$16.1K -1,056 -56%
Goldman Sachs
29
Goldman Sachs
New York
$11.1K +$473 +31 +5%
EGM
30
Engineers Gate Manager
New York
$7.73K – – –
PWM
31
Palumbo Wealth Management
New York
$6.45K +$6.38K +418 New
Barclays
32
Barclays
United Kingdom
$6.32K – – –
Bank of America
33
Bank of America
North Carolina
$5.49K -$15 -1 -0.3%
Morgan Stanley
34
Morgan Stanley
New York
$4.48K -$4.45K -292 -50%
TRCT
35
Tower Research Capital (TRC)
New York
$3.06K -$442 -29 -13%
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$1K -$397 -26 -28%
DWS
37
Dynamic Wealth Strategies
California
$1K – – –
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$854 – – –
Qube Research & Technologies (QRT)
39
Qube Research & Technologies (QRT)
United Kingdom
$351 – – –
Wells Fargo
40
Wells Fargo
California
$197 – – –
HI
41
Harbour Investments
Wisconsin
$88 – – –
Citigroup
42
Citigroup
New York
$15 – – –
Bank of Montreal
43
Bank of Montreal
Ontario, Canada
– -$481K -32,750 Closed
Cambridge Investment Research Advisors
44
Cambridge Investment Research Advisors
Iowa
– -$12K -878 Closed
Bank of New York Mellon
45
Bank of New York Mellon
New York
– -$11.8K -851 Closed
BRG
46
Bay Rivers Group
Virginia
– -$6.44K -467 Closed
TSS
47
Two Sigma Securities
New York
– -$5.78K -419 Closed
DI
48
DAGCO Inc
Ohio
– -$782 -57 Closed
1
2

OMIC Hedge Fund Activity: Q1 2024 in Review

42 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q1 2024, worth a combined $13.1M — up 8% from $12.1M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of OMIC and 2 opened new positions — a net loss of 5 holders — while 10 trimmed existing stakes and 7 added.

The largest buyer was QVIDTVM Management, adding an estimated $95.1K. The largest seller was Bank of Montreal, exiting entirely with an estimated $481K sold.

  • 42 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q1 2024, down from 47 in Q4 2023.
  • Funds reported $13.1M of Singular Genomics Systems, Inc. Common Stock stock for Q1 2024, up 8% quarter-over-quarter.
  • 2 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q1 2024 and 7 closed out, a net change of -5 holders.
  • The largest Singular Genomics Systems, Inc. Common Stock buyer in Q1 2024 was QVIDTVM Management, an estimated $95.1K added.
  • The largest Singular Genomics Systems, Inc. Common Stock seller in Q1 2024 was Bank of Montreal, an estimated $481K sold.

Based on aggregated 13F filings for Q1 2024.